Join Growin Stock Community!

永日4102.TW Overview

TW StockBiotech. & Medical
(No presentation for 4102)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

永日（4102）Overall Performance

永日（4102）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

永日（4102） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

永日（4102）Key Information

永日（4102）Profile

Yung Zip Chemical Ind. Co., Ltd., a bulk drug manufacturing company, supplies active pharmaceutical ingredients (APIs), API intermediates, and specialty chemicals worldwide. It offers antihypertensive, iron chelator, anti-inflammatory, analgesic, antipyretic, anti-fungal, schizophrenia, anticoagulant, genital herpes outbreak, hypnotic, and sedative products. The company also offers excipients, such as sodium starch glycolate; and custom research and manufacturing services. Yung Zip Chemical Ind. Co., Ltd was founded in 1978 and is based in Taichung, Taiwan.

永日（4102）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
38.85
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
19.08%
Net Margin
-3.79%
Revenue Growth (YoY)
-22.04%
Profit Growth (YoY)
-53.97%
3-Year Revenue Growth
-12.34%
3-Year Profit Growth
-32.62%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
38.85
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
19.08%
Net Margin
-3.79%
Revenue Growth (YoY)
-22.04%
Profit Growth (YoY)
-53.97%
3-Year Revenue Growth
-12.34%
3-Year Profit Growth
-32.62%
default symbol

4102

永日

20.20D

0.99%

(0.01)

  • When is 4102's latest earnings report released?

    The most recent financial report for 永日 (4102) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4102's short-term business performance and financial health. For the latest updates on 4102's earnings releases, visit this page regularly.

  • What is the operating profit of 4102?

    According to the latest financial report, 永日 (4102) reported an Operating Profit of -14.99M with an Operating Margin of -14.39% this period, representing a decline of 186.18% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4102's revenue growth?

    In the latest financial report, 永日 (4102) announced revenue of 104.16M, with a Year-Over-Year growth rate of -33.5%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4102 have?

    At the end of the period, 永日 (4102) held Total Cash and Cash Equivalents of 108.76M, accounting for 0.12 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4102 go with three margins increasing?

    In the latest report, 永日 (4102) did not achieve the “three margins increasing” benchmark, with a gross margin of 14.7%%, operating margin of -14.39%%, and net margin of -2.35%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4102's profit trajectory and future growth potential.

  • Is 4102's EPS continuing to grow?

    According to the past four quarterly reports, 永日 (4102)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.08. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4102?

    永日 (4102)'s Free Cash Flow (FCF) for the period is 9.73M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 54.91% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.